Mouwasat Medical Services Co.'s net profit after zakat and tax rose 1.9 percent year-on-year (YoY) to SAR 197.5 million in H1 2019 driven by higher revenue from expansion in sub-specialty clinics and launch of new specialized departments.
The earnings were also bolstered by the continuous effective utilization of available resources.
Item | 6m 2018 | 6m 2019 | Change |
---|---|---|---|
Revenues | 816.71 | 908.88 | 11.3 % |
Gross Income | 385.74 | 405.52 | 5.1 % |
Operating Income | 214.98 | 226.08 | 5.2 % |
Net Income | 193.89 | 197.53 | 1.9 % |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.97 | 0.99 | 1.9 % |
The second quarter net profit after zakat and tax grew by 2.8 percent YoY to SAR 90.3 million due to the same reasons.
When compared to Q1 2019, net profit after zakat and tax dropped 15.8 percent on a decline in revenue amid summer season, Ramadan and Eid Al-Fitr.
Item | Q2 2018 | Q2 2019 | Change |
---|---|---|---|
Revenues | 394.35 | 446.26 | 13.2 % |
Gross Income | 185.90 | 194.20 | 4.5 % |
Operating Income | 98.77 | 104.04 | 5.3 % |
Net Income | 87.88 | 90.31 | 2.8 % |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.44 | 0.45 | 2.8 % |
Item | Q1 2019 | Q2 2019 | Change |
---|---|---|---|
Revenues | 462.62 | 446.26 | (3.5 %) |
Gross Income | 211.32 | 194.20 | (8.1 %) |
Operating Income | 122.04 | 104.04 | (14.7 %) |
Net Income | 107.22 | 90.31 | (15.8 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.54 | 0.45 | (15.8 %) |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2010 | 143.79 | 15.4 % | 68.04 | 21.0 % | 32.37 | 21.9 % | 0.16 |
Q2 2010 | 148.78 | 5.8 % | 71.36 | 5.3 % | 34.77 | 2.2 % | 0.17 |
Q3 2010 | 134.72 | 16.9 % | 63.30 | 17.1 % | 23.14 | 5.8 % | 0.12 |
Q4 2010 | 160.20 | 16.8 % | 74.36 | 48.9 % | 28.28 | 15.1 % | 0.14 |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
Q1 2011 | 166.82 | 16.0 % | 84.05 | 23.5 % | 39.14 | 20.9 % | 0.20 |
Q2 2011 | 164.93 | 10.9 % | 76.76 | 7.6 % | 40.49 | 16.4 % | 0.20 |
Q3 2011 | 156.92 | 16.5 % | 74.10 | 17.1 % | 33.71 | 45.7 % | 0.17 |
Q4 2011 | 189.77 | 18.5 % | 89.09 | 19.8 % | 34.72 | 22.8 % | 0.17 |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
Q1 2012 | 195.57 | 17.2 % | 94.32 | 12.2 % | 46.34 | 18.4 % | 0.23 |
Q2 2012 | 200.62 | 21.6 % | 93.28 | 21.5 % | 47.26 | 16.7 % | 0.24 |
Q3 2012 | 187.28 | 19.3 % | 84.01 | 13.4 % | 35.44 | 5.1 % | 0.18 |
Q4 2012 | 213.04 | 12.3 % | 101.10 | 13.5 % | 42.56 | 22.6 % | 0.21 |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
Q1 2013 | 219.23 | 12.1 % | 110.39 | 17.0 % | 52.52 | 13.3 % | 0.26 |
Q2 2013 | 228.74 | 14.0 % | 116.90 | 25.3 % | 54.16 | 14.6 % | 0.27 |
Q3 2013 | 211.63 | 13.0 % | 104.34 | 24.2 % | 44.11 | 24.5 % | 0.22 |
Q4 2013 | 242.64 | 13.9 % | 124.17 | 22.8 % | 50.42 | 18.4 % | 0.25 |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
Q1 2014 | 243.54 | 11.1 % | 124.18 | 12.5 % | 57.94 | 10.3 % | 0.29 |
Q2 2014 | 244.25 | 6.8 % | 124.14 | 6.2 % | 59.44 | 9.8 % | 0.30 |
Q3 2014 | 230.47 | 8.9 % | 113.02 | 8.3 % | 71.99 | 63.2 % | 0.36 |
Q4 2014 | 247.18 | 1.9 % | 117.49 | (5.4 %) | 50.75 | 0.7 % | 0.25 |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
Q1 2015 | 253.41 | 4.1 % | 118.63 | (4.5 %) | 55.93 | (3.5 %) | 0.28 |
Q2 2015 | 255.10 | 4.4 % | 115.78 | (6.7 %) | 56.09 | (5.6 %) | 0.28 |
Q3 2015 | 231.63 | 0.5 % | 98.68 | (12.7 %) | 42.99 | (40.3 %) | 0.21 |
Q4 2015 | 259.94 | 5.2 % | 113.72 | (3.2 %) | 53.80 | 6.0 % | 0.27 |
2015 | 1,000.08 | 10.7 % | 446.81 | 7.1 % | 208.80 | (13.0 %) | 1.04 |
Q1 2016 | 303.59 | 19.8 % | 143.50 | 21.0 % | 68.47 | 22.4 % | 0.34 |
Q2 2016 | 300.21 | 17.7 % | 139.76 | 20.7 % | 63.70 | 13.6 % | 0.32 |
Q3 2016 | 280.24 | 21.0 % | 124.29 | 26.0 % | 49.36 | 14.8 % | 0.25 |
Q4 2016 | 359.19 | 38.2 % | 168.91 | 48.5 % | 75.65 | 40.6 % | 0.38 |
2016 | 1,243.22 | 24.3 % | 576.45 | 29.0 % | 257.18 | 23.2 % | 1.29 |
Q1 2017 | 362.97 | 19.6 % | 173.37 | 20.8 % | 85.12 | 24.3 % | 0.43 |
Q2 2017 | 353.24 | 17.7 % | 163.53 | 17.0 % | 76.34 | 19.8 % | 0.38 |
Q3 2017 | 359.47 | 28.3 % | 164.38 | 32.3 % | 76.73 | 55.4 % | 0.38 |
Q4 2017 | 431.45 | 20.1 % | 210.90 | 24.9 % | 98.55 | 30.3 % | 0.49 |
2017 | 1,507.14 | 21.2 % | 712.17 | 23.5 % | 336.73 | 30.9 % | 1.68 |
Q1 2018 | 422.35 | 16.4 % | 199.84 | 15.3 % | 106.01 | 24.5 % | 0.53 |
Q2 2018 | 394.35 | 11.6 % | 185.90 | 13.7 % | 87.88 | 15.1 % | 0.44 |
Q3 2018 | 404.27 | 12.5 % | 182.64 | 11.1 % | 80.89 | 5.4 % | 0.40 |
Q4 2018 | 456.04 | 5.7 % | 205.12 | (2.7 %) | 85.43 | (13.3 %) | 0.43 |
2018 | 1,677.02 | 11.3 % | 773.50 | 8.6 % | 360.21 | 7.0 % | 1.80 |
Q1 2019 | 462.62 | 9.5 % | 211.32 | 5.7 % | 107.22 | 1.1 % | 0.54 |
Q2 2019 | 446.26 | 13.2 % | 194.20 | 4.5 % | 90.31 | 2.8 % | 0.45 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 107.04 | 10.3 % | 0.54 |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 118.57 | 10.8 % | 0.59 |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 148.06 | 24.9 % | 0.74 |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 171.60 | 15.9 % | 0.86 |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 201.20 | 17.3 % | 1.01 |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 240.12 | 19.3 % | 1.20 |
2015 | 1,000.08 | 10.7 % | 446.81 | 7.1 % | 208.80 | (13.0 %) | 1.04 |
2016 | 1,243.22 | 24.3 % | 576.45 | 29.0 % | 257.18 | 23.2 % | 1.29 |
2017 | 1,507.14 | 21.2 % | 712.17 | 23.5 % | 336.73 | 30.9 % | 1.68 |
2018 | 1,677.02 | 11.3 % | 773.50 | 8.6 % | 360.21 | 7.0 % | 1.80 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 44.67 % | 30.72 % | 21.03 % |
Q2 2010 | 44.66 % | 30.02 % | 20.85 % |
Q3 2010 | 44.76 % | 28.94 % | 20.35 % |
Q4 2010 | 47.16 % | 30.15 % | 20.18 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
Q1 2011 | 48.00 % | 29.97 % | 20.53 % |
Q2 2011 | 47.63 % | 29.54 % | 20.91 % |
Q3 2011 | 47.66 % | 30.31 % | 21.83 % |
Q4 2011 | 47.76 % | 30.40 % | 21.82 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
Q1 2012 | 47.27 % | 30.32 % | 21.95 % |
Q2 2012 | 47.22 % | 30.30 % | 21.81 % |
Q3 2012 | 46.65 % | 28.88 % | 21.18 % |
Q4 2012 | 46.79 % | 28.28 % | 21.54 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
Q1 2013 | 47.40 % | 28.13 % | 21.68 % |
Q2 2013 | 48.62 % | 28.20 % | 21.77 % |
Q3 2013 | 49.59 % | 28.72 % | 22.16 % |
Q4 2013 | 50.52 % | 29.11 % | 22.30 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
Q1 2014 | 50.68 % | 28.86 % | 22.30 % |
Q2 2014 | 50.62 % | 28.77 % | 22.49 % |
Q3 2014 | 50.53 % | 28.82 % | 22.70 % |
Q4 2014 | 49.60 % | 28.54 % | 22.40 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
Q1 2015 | 48.53 % | 28.38 % | 21.96 % |
Q2 2015 | 47.14 % | 28.23 % | 21.38 % |
Q3 2015 | 45.64 % | 28.05 % | 20.62 % |
Q4 2015 | 44.68 % | 28.92 % | 20.88 % |
2015 | 44.68 % | 28.92 % | 20.88 % |
Q1 2016 | 44.91 % | 29.32 % | 21.08 % |
Q2 2016 | 45.25 % | 29.52 % | 20.90 % |
Q3 2016 | 45.57 % | 29.40 % | 20.57 % |
Q4 2016 | 46.37 % | 29.27 % | 20.69 % |
2016 | 46.37 % | 29.27 % | 20.69 % |
Q1 2017 | 46.55 % | 29.66 % | 21.02 % |
Q2 2017 | 46.48 % | 29.75 % | 21.13 % |
Q3 2017 | 46.71 % | 30.51 % | 21.87 % |
Q4 2017 | 47.25 % | 30.73 % | 22.34 % |
2017 | 47.25 % | 30.73 % | 22.34 % |
Q1 2018 | 47.15 % | 31.21 % | 22.83 % |
Q2 2018 | 47.34 % | 31.39 % | 22.96 % |
Q3 2018 | 47.16 % | 30.90 % | 22.59 % |
Q4 2018 | 46.12 % | 30.64 % | 21.48 % |
2018 | 46.12 % | 30.64 % | 21.48 % |
Q1 2019 | 45.71 % | 30.83 % | 21.05 % |
Q2 2019 | 44.84 % | 30.84 % | 20.57 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2009 | 44.05 % | 30.06 % | 20.68 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
2015 | 44.68 % | 28.92 % | 20.88 % |
2016 | 46.37 % | 29.27 % | 20.69 % |
2017 | 47.25 % | 30.73 % | 22.34 % |
2018 | 46.12 % | 30.64 % | 21.48 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 47.32 % | 33.89 % | 22.51 % |
Q2 2010 | 47.96 % | 32.68 % | 23.37 % |
Q3 2010 | 46.98 % | 27.76 % | 17.18 % |
Q4 2010 | 46.42 % | 26.45 % | 17.65 % |
Q1 2011 | 50.38 % | 32.72 % | 23.46 % |
Q2 2011 | 46.54 % | 30.78 % | 24.55 % |
Q3 2011 | 47.22 % | 31.20 % | 21.48 % |
Q4 2011 | 46.95 % | 27.37 % | 18.29 % |
Q1 2012 | 48.23 % | 32.08 % | 23.69 % |
Q2 2012 | 46.49 % | 30.64 % | 23.56 % |
Q3 2012 | 44.86 % | 25.18 % | 18.92 % |
Q4 2012 | 47.46 % | 25.28 % | 19.98 % |
Q1 2013 | 50.35 % | 31.12 % | 23.96 % |
Q2 2013 | 51.11 % | 30.61 % | 23.68 % |
Q3 2013 | 49.30 % | 27.68 % | 20.84 % |
Q4 2013 | 51.18 % | 27.14 % | 20.78 % |
Q1 2014 | 50.99 % | 29.94 % | 23.79 % |
Q2 2014 | 50.83 % | 30.16 % | 24.34 % |
Q3 2014 | 49.04 % | 27.98 % | 21.82 % |
Q4 2014 | 47.53 % | 26.09 % | 19.64 % |
Q1 2015 | 46.81 % | 29.28 % | 22.07 % |
Q2 2015 | 45.38 % | 29.50 % | 21.99 % |
Q3 2015 | 42.60 % | 27.19 % | 18.56 % |
Q4 2015 | 43.75 % | 29.55 % | 20.70 % |
Q1 2016 | 47.27 % | 30.60 % | 22.55 % |
Q2 2016 | 46.55 % | 30.20 % | 21.22 % |
Q3 2016 | 44.35 % | 27.12 % | 17.62 % |
Q4 2016 | 47.02 % | 29.03 % | 21.06 % |
Q1 2017 | 47.76 % | 31.79 % | 23.45 % |
Q2 2017 | 46.29 % | 30.47 % | 21.61 % |
Q3 2017 | 45.73 % | 30.75 % | 21.34 % |
Q4 2017 | 48.88 % | 30.03 % | 22.84 % |
Q1 2018 | 47.32 % | 33.44 % | 25.10 % |
Q2 2018 | 47.14 % | 31.26 % | 22.28 % |
Q3 2018 | 45.18 % | 28.81 % | 20.01 % |
Q4 2018 | 44.98 % | 29.14 % | 18.73 % |
Q1 2019 | 45.68 % | 33.91 % | 23.18 % |
Q2 2019 | 43.52 % | 31.23 % | 20.24 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2010 | 200.00 | 0.56 | 0.56 | 2.56 |
Q2 2010 | 200.00 | 0.57 | 0.57 | 2.61 |
Q3 2010 | 200.00 | 0.57 | 0.57 | 2.72 |
Q4 2010 | 200.00 | 0.59 | 0.59 | 2.86 |
Q1 2011 | 200.00 | 0.63 | 0.63 | 3.06 |
Q2 2011 | 200.00 | 0.66 | 0.66 | 3.01 |
Q3 2011 | 200.00 | 0.71 | 0.71 | 3.18 |
Q4 2011 | 200.00 | 0.74 | 0.74 | 3.34 |
Q1 2012 | 200.00 | 0.78 | 0.78 | 3.57 |
Q2 2012 | 200.00 | 0.81 | 0.81 | 3.44 |
Q3 2012 | 200.00 | 0.82 | 0.82 | 3.61 |
Q4 2012 | 200.00 | 0.86 | 0.86 | 3.82 |
Q1 2013 | 200.00 | 0.89 | 0.89 | 4.08 |
Q2 2013 | 200.00 | 0.92 | 0.92 | 3.98 |
Q3 2013 | 200.00 | 0.97 | 0.97 | 4.20 |
Q4 2013 | 200.00 | 1.01 | 1.01 | 4.44 |
Q1 2014 | 200.00 | 1.03 | 1.03 | 4.73 |
Q2 2014 | 200.00 | 1.06 | 1.06 | 4.53 |
Q3 2014 | 200.00 | 1.20 | 1.09 | 4.89 |
Q4 2014 | 200.00 | 1.20 | 1.08 | 5.14 |
Q1 2015 | 200.00 | 1.19 | 1.07 | 5.42 |
Q2 2015 | 200.00 | 1.17 | 1.05 | 5.20 |
Q3 2015 | 200.00 | 1.03 | 1.02 | 5.41 |
Q4 2015 | 200.00 | 1.04 | 1.04 | 5.67 |
Q1 2016 | 200.00 | 1.11 | 1.11 | 5.96 |
Q2 2016 | 200.00 | 1.14 | 1.14 | 5.84 |
Q3 2016 | 200.00 | 1.18 | 1.18 | 6.09 |
Q4 2016 | 200.00 | 1.29 | 1.29 | 6.38 |
Q1 2017 | 200.00 | 1.37 | 1.37 | 6.81 |
Q2 2017 | 200.00 | 1.43 | 1.43 | 6.57 |
Q3 2017 | 200.00 | 1.57 | 1.57 | 6.95 |
Q4 2017 | 200.00 | 1.68 | 1.68 | 7.45 |
Q1 2018 | 200.00 | 1.79 | 1.79 | 8.04 |
Q2 2018 | 200.00 | 1.85 | 1.85 | 7.73 |
Q3 2018 | 200.00 | 1.87 | 1.87 | 8.14 |
Q4 2018 | 200.00 | 1.80 | 1.80 | 8.56 |
Q1 2019 | 200.00 | 1.81 | 1.81 | 9.10 |
Q2 2019 | 200.00 | 1.82 | 1.82 | 8.68 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2009 | 200.00 | 0.54 | 0.54 | 2.40 |
2010 | 200.00 | 0.59 | 0.59 | 2.86 |
2011 | 200.00 | 0.74 | 0.74 | 3.34 |
2012 | 200.00 | 0.86 | 0.86 | 3.82 |
2013 | 200.00 | 1.01 | 1.01 | 4.44 |
2014 | 200.00 | 1.20 | 1.08 | 5.14 |
2015 | 200.00 | 1.04 | 1.04 | 5.67 |
2016 | 200.00 | 1.29 | 1.29 | 6.38 |
2017 | 200.00 | 1.68 | 1.68 | 7.45 |
2018 | 200.00 | 1.80 | 1.80 | 8.56 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2010 | 13.68 | 13.68 | 3.02 |
Q2 2010 | 14.64 | 14.64 | 3.19 |
Q3 2010 | 14.75 | 14.75 | 3.11 |
Q4 2010 | 15.18 | 15.18 | 3.15 |
Q1 2011 | 13.52 | 13.52 | 2.77 |
Q2 2011 | 16.08 | 16.08 | 3.50 |
Q3 2011 | 13.29 | 13.29 | 2.96 |
Q4 2011 | 15.92 | 15.92 | 3.53 |
Q1 2012 | 16.83 | 16.83 | 3.66 |
Q2 2012 | 13.89 | 13.89 | 3.27 |
Q3 2012 | 15.57 | 15.57 | 3.53 |
Q4 2012 | 15.66 | 15.66 | 3.52 |
Q1 2013 | 18.00 | 18.00 | 3.92 |
Q2 2013 | 18.62 | 18.62 | 4.32 |
Q3 2013 | 21.21 | 21.21 | 4.88 |
Q4 2013 | 22.86 | 22.86 | 5.18 |
Q1 2014 | 21.78 | 21.78 | 4.75 |
Q2 2014 | 24.19 | 24.19 | 5.66 |
Q3 2014 | 26.21 | 28.82 | 6.43 |
Q4 2014 | 25.71 | 28.55 | 6.01 |
Q1 2015 | 27.98 | 31.11 | 6.15 |
Q2 2015 | 30.38 | 33.83 | 6.86 |
Q3 2015 | 29.89 | 30.21 | 5.68 |
Q4 2015 | 29.17 | 29.17 | 5.37 |
Q1 2016 | 25.75 | 25.75 | 4.78 |
Q2 2016 | 28.12 | 28.12 | 5.51 |
Q3 2016 | 25.07 | 25.07 | 4.84 |
Q4 2016 | 28.74 | 28.74 | 5.79 |
Q1 2017 | 26.02 | 26.02 | 5.23 |
Q2 2017 | 27.61 | 27.61 | 6.02 |
Q3 2017 | 25.29 | 25.29 | 5.71 |
Q4 2017 | 22.48 | 22.48 | 5.08 |
Q1 2018 | 24.64 | 24.64 | 5.48 |
Q2 2018 | 25.46 | 25.46 | 6.08 |
Q3 2018 | 22.23 | 22.23 | 5.10 |
Q4 2018 | 22.35 | 22.35 | 4.70 |
Q1 2019 | 22.22 | 22.22 | 4.41 |
Q2 2019 | 24.74 | 24.74 | 5.19 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2009 | 14.31 | 14.31 | 3.19 |
2010 | 15.18 | 15.18 | 3.15 |
2011 | 15.92 | 15.92 | 3.53 |
2012 | 15.66 | 15.66 | 3.52 |
2013 | 22.86 | 22.86 | 5.18 |
2014 | 25.71 | 28.55 | 6.01 |
2015 | 29.17 | 29.17 | 5.37 |
2016 | 28.74 | 28.74 | 5.79 |
2017 | 22.48 | 22.48 | 5.08 |
2018 | 22.35 | 22.35 | 4.70 |
Q2 2019
2019
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
Q1 2010 | 109.41 | 32.47 | 1.92 |
Q2 2010 | 114.73 | 34.05 | - |
Q3 2010 | 102.85 | 31.87 | - |
Q4 2010 | 118.91 | 41.29 | - |
Q1 2011 | 129.63 | 37.19 | - |
Q2 2011 | 128.04 | 36.89 | - |
Q3 2011 | 123.09 | 33.84 | - |
Q4 2011 | 149.24 | 40.52 | - |
Q1 2012 | 155.38 | 40.19 | - |
Q2 2012 | 159.24 | 41.38 | - |
Q3 2012 | 149.51 | 37.77 | - |
Q4 2012 | 168.11 | 44.93 | - |
Q1 2013 | 177.18 | 42.05 | - |
Q2 2013 | 186.71 | 42.02 | - |
Q3 2013 | 172.61 | 39.02 | - |
Q4 2013 | 182.05 | 45.21 | - |
Q1 2014 | 196.67 | 46.87 | - |
Q2 2014 | 198.14 | 46.10 | - |
Q3 2014 | 186.70 | 43.78 | - |
Q4 2014 | 137.05 | 48.48 | - |
Q1 2015 | 201.34 | 52.07 | - |
Q2 2015 | 205.21 | 49.89 | - |
Q3 2015 | 189.98 | 41.65 | - |
Q4 2015 | 213.59 | 46.36 | - |
Q1 2016 | 251.45 | 52.14 | - |
Q2 2016 | 250.70 | 49.51 | - |
Q3 2016 | 235.92 | 44.32 | - |
Q4 2016 | 306.32 | 52.87 | - |
Q1 2017 | 310.82 | 52.15 | - |
Q2 2017 | 301.62 | 51.62 | - |
Q3 2017 | 308.40 | 51.07 | - |
Q4 2017 | 368.74 | 62.71 | - |
Q1 2018 | 360.78 | 61.57 | - |
Q2 2018 | 341.76 | 52.59 | - |
Q3 2018 | 345.96 | 54.14 | - |
Q4 2018 | 393.17 | 62.87 | - |
Q1 2019 | 396.75 | 65.87 | - |
Q2 2019 | 385.57 | 60.69 | - |
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
2009 | 396.28 | 117.25 | 4.07 |
2010 | 445.90 | 139.68 | 1.92 |
2011 | 530.00 | 148.44 | - |
2012 | 632.24 | 164.27 | - |
2013 | 718.55 | 168.30 | - |
2014 | 718.55 | 185.23 | - |
2015 | 810.12 | 189.96 | - |
2016 | 1,044.39 | 198.83 | - |
2017 | 1,289.59 | 217.55 | - |
2018 | 1,441.68 | 235.34 | - |
Item | Q2 2019 (e) | Q2 2019 (a) | Change |
---|---|---|---|
Average | 91.23 | 90.31 | (1.0 %) |
Item | Q2 2019 (e) | Q2 2019 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 90.00 | 90.31 | 0.3 % |
SNB Capital | 92.00 | 90.31 | (1.8) % |
AlJazira Capital | 83.90 | 90.31 | 7.6 % |
Al Rajhi Capital | 99.00 | 90.31 | (8.8) % |
Current | |
Market Cap (M Riyal) | 24,440.00 |
Enterprise Value (EV) (M) | 25,206.83 |
Shares Outstanding ((M)) | 200.00 |
EPS ( Riyal) (TTM) | 3.30 |
Book Value (BV) ( Riyal) | 17.24 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 37.08 |
P/E (TTM) | 37.08 |
Price/book | 7.09 |
Return on Average Assets (%) (TTM) | 13.5 |
Return on Average Equity (%) (TTM) | 20.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}